Transcriptome analysis of effects of Tecrl deficiency on cardiometabolic and calcium regulation in cardiac tissue
- PMID: 38283583
- PMCID: PMC10811529
- DOI: 10.1515/med-2023-0880
Transcriptome analysis of effects of Tecrl deficiency on cardiometabolic and calcium regulation in cardiac tissue
Abstract
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a hereditary heart disease characterized by bidirectional or polymorphic ventricular tachycardia and an increased risk of sudden cardiac death. Although trans-2,3-enoyl-CoA reductase like (TECRL) is a newly reported pathogenic gene leading to CPVT that can influence intracellular calcium regulation, the unidentified mechanism underlying the pathogenesis of TECRL deficiency-mediated CPVT remains mainly elusive. In the present study, Tecrl knockout (KO) mice were established and the differentially expressed genes (DEGs) were investigated by RNA-sequencing from the heart tissues. In addition, 857 DEGs were identified in Tecrl KO mice. Subsequently, a weighted gene co-expression network analysis was conducted to discern the pivotal pathways implicated in the Tecrl-mediated regulatory network. Moreover, pathway mapping analyses demonstrated that essential metabolism-related pathways were significantly enriched, notably the fatty acid metabolic process and calcium regulation. Collectively, the data suggested a synergistic relationship between Tecrl deficiency and cardiometabolic and calcium regulation during the development of CPVT. Therefore, further studies on the potential function of TECRL in cardiac tissues would be beneficial to elucidate the pathogenesis of CPVT.
Keywords: RNA-seq; Tecrl; WGCNA; catecholaminergic polymorphic ventricular tachycardia.
© 2024 the author(s), published by De Gruyter.
Conflict of interest statement
Conflict of interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10811529/bin/j_med-2023-0880-fig001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10811529/bin/j_med-2023-0880-fig002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10811529/bin/j_med-2023-0880-fig003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10811529/bin/j_med-2023-0880-fig004.gif)
Similar articles
-
A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family.Eur J Med Genet. 2019 Jul;62(7):103631. doi: 10.1016/j.ejmg.2019.01.018. Epub 2019 Feb 18. Eur J Med Genet. 2019. PMID: 30790670
-
Novel variants in TECRL cause recessive inherited CPVT type 3 with severe and variable clinical symptoms.J Cardiovasc Electrophysiol. 2020 Jun;31(6):1527-1535. doi: 10.1111/jce.14446. Epub 2020 Mar 22. J Cardiovasc Electrophysiol. 2020. PMID: 32173957
-
TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.EMBO Mol Med. 2016 Dec 1;8(12):1390-1408. doi: 10.15252/emmm.201505719. Print 2016 Dec. EMBO Mol Med. 2016. PMID: 27861123 Free PMC article.
-
BASIC AND CLINICAL INSIGHTS IN CATECHOLAMINERGIC (FAMILIAL) POLYMORPHIC VENTRICULAR TACHYCARDIA.Rev Invest Clin. 2019;71(4):226-236. doi: 10.24875/RIC.19002939. Rev Invest Clin. 2019. PMID: 31448784 Review.
-
Current topics in catecholaminergic polymorphic ventricular tachycardia.J Arrhythm. 2016 Oct;32(5):344-351. doi: 10.1016/j.joa.2015.09.008. Epub 2015 Nov 24. J Arrhythm. 2016. PMID: 27761157 Free PMC article. Review.
Cited by
-
Novel Compound Heterozygous Variants in Trans-2,3-Enoyl-Coenzyme A Reductase-Like Gene Associated With Catecholaminergic Polymorphic Ventricular Tachycardia.JACC Case Rep. 2024 May 7;29(11):102364. doi: 10.1016/j.jaccas.2024.102364. eCollection 2024 Jun 5. JACC Case Rep. 2024. PMID: 38756419 Free PMC article.
References
-
- Priori SG, Mazzanti A, Santiago DJ, Kukavica D, Trancuccio A, Kovacic JC. Precision medicine in catecholaminergic polymorphic ventricular tachycardia: JACC focus seminar 5/5. J Am Coll Cardiol. 2021;77(20):2592–612. - PubMed
-
- Päivi J, Laitinen B, Kevin M, Brown B, Kirsi Piippo M, Heikki Swan M, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485–90. - PubMed
-
- Silvia G, Priori M, Carlo Napolitano M, Natascia Tiso P, Mirella Memmi P, Gabriele Vignati M, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200. - PubMed
-
- Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001;69(6):1378–84. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials